Brokerages Cut Alkami Targets to $25 as Q3 ARR Hits $449M

ALKTALKT

Alkami posted $449M in third-quarter ARR, with revenue up 31.5% in Q3 and 36% in Q2 on 96% subscription-based income and 20.9M users. Brokerages set a $36 average price target with six buys, though top targets have slid from $46 to as low as $25.

1. Revenue Model and Accelerating ARR

Alkami Technology’s business is underpinned by a highly recurring, subscription-based revenue model, with approximately 96% of its income derived from SaaS fees and implementation services. In Q3 2025 the company reported annual recurring revenue of $449 million, up from $X in the prior year quarter, and saw registered users climb to 20.9 million. Top-line momentum remains robust: revenue grew 36% year-over-year in Q2 2025 and 31.5% in Q3, reflecting deepening adoption of its cloud-based digital banking platform by community banks and credit unions.

2. Factors Driving the Stock’s Recent Decline

Despite strong ARR growth, the share price has retreated roughly 50% from late 2024 highs. A Q2 earnings miss on EPS expectations, coupled with more cautious guidance from management, rattled short-term sentiment. High investment levels in product development and sales continue to pressure GAAP profitability, raising concern among investors focused on near-term earnings. At the same time, attention has shifted to high-profile AI names, leaving Alkami’s fintech story underappreciated in broader market rotations.

3. Analyst Ratings and Institutional Positioning

Of the ten brokerages covering the stock, six maintain a buy rating, three are at hold, and one recommends sell, producing a consensus price target of $36.00. Insider Douglas Linebarger sold 8,179 shares at an average of $20.34 in early December, reducing his stake by 3.56%. Institutional ownership stands at 54.97%, with notable activity including SG Americas Securities boosting its holding by 735.1% to 213,979 shares and Long Path Partners increasing its position to 2.57 million shares. This combination of bullish analyst targets and substantial stake accumulation by funds underscores confidence that Alkami is well positioned for a rebound.

Sources

FD